FOUNDER, CHAIRMAN AND CEO
- 20 years of experience in the global healthcare industry
- Chairman, CEO Ruthigen, Inc.
- IPO experience, including raising $170M in capital
- FDA and CE approvals of multiple drugs and devices
CO-FOUNDER, VP OF BUSINESS DEVELOPMENT AND SALES
- Vice President, Sales and Business Development
- Investment Banker completed over $400M in transactions
- Director of National Investment Bankers Association
DIRECTOR OF FINANCE
- Served as Chief Financial Officer of Ruthigen, Inc.
- Buy-side and Sell-side equity research analyst covering medical devices and diagnostics sectors with Symmetry Capital, Needham & Co., and ThinkEquity
- Held research positions at Guidant (now Abbott Laboratories) and Synteni (acquired by Incyte Corporation)